Additionally, BM-MSCs have been shown to protect against liver fibrosis and promote the recovery of injured liver function, as shown by reduced serum levels of AST, ALT, ALP, total bilirubin, and improved histological lesions of liver tissue. This evidence concerns the gene GPT and Hepatic fibrosis.